Compare AANJANEYA LIFECARE with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SHASUN PHARMA DR. DATSONS LABS/
SHASUN PHARMA
 
P/E (TTM) x -10.9 123.9 - View Chart
P/BV x 0.2 8.5 1.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   SHASUN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SHASUN PHARMA
Mar-14
DR. DATSONS LABS/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs12694 133.3%   
Low Rs3146 67.8%   
Sales per share (Unadj.) Rs133.0214.2 62.1%  
Earnings per share (Unadj.) Rs0.25.3 2.8%  
Cash flow per share (Unadj.) Rs6.615.8 41.8%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs128.853.3 241.4%  
Shares outstanding (eoy) m31.6656.62 55.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 180.3%   
Avg P/E ratio x516.113.1 3,939.9%  
P/CF ratio (eoy) x11.84.4 268.0%  
Price / Book Value ratio x0.61.3 46.4%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m2,4773,958 62.6%   
No. of employees `000NANA-   
Total wages/salary Rs m562,164 2.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21112,127 34.7%  
Other income Rs m79229 34.3%   
Total revenues Rs m4,28912,356 34.7%   
Gross profit Rs m5691,009 56.4%  
Depreciation Rs m204594 34.4%   
Interest Rs m430415 103.6%   
Profit before tax Rs m13230 5.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20 600.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-73 -8.4%   
Profit after tax Rs m5302 1.6%  
Gross profit margin %13.58.3 162.3%  
Effective tax rate %48.0-31.7 -151.7%   
Net profit margin %0.12.5 4.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,884 99.5%   
Current liabilities Rs m6,7118,456 79.4%   
Net working cap to sales %3.3-13.0 -25.8%  
Current ratio x1.00.8 125.4%  
Inventory Days Days16162 261.0%  
Debtors Days Days318108 296.1%  
Net fixed assets Rs m3,6734,970 73.9%   
Share capital Rs m317113 279.4%   
"Free" reserves Rs m3,7612,875 130.8%   
Net worth Rs m4,0783,020 135.0%   
Long term debt Rs m1,6711,817 91.9%   
Total assets Rs m12,63313,347 94.6%  
Interest coverage x1.01.6 66.3%   
Debt to equity ratio x0.40.6 68.1%  
Sales to assets ratio x0.30.9 36.7%   
Return on assets %3.45.4 64.1%  
Return on equity %0.110.0 1.2%  
Return on capital %7.713.3 57.6%  
Exports to sales %22.946.4 49.4%   
Imports to sales %14.314.2 100.3%   
Exports (fob) Rs m9645,622 17.1%   
Imports (cif) Rs m6021,728 34.8%   
Fx inflow Rs m9645,843 16.5%   
Fx outflow Rs m6072,173 27.9%   
Net fx Rs m3573,669 9.7%   
CASH FLOW
From Operations Rs m1,345398 338.2%  
From Investments Rs m-2,256-1,635 138.0%  
From Financial Activity Rs m-1,2001,309 -91.7%  
Net Cashflow Rs m-2,11171 -2,964.5%  

Share Holding

Indian Promoters % 4.5 39.2 11.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 1.4 17.6 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 39.6 237.6%  
Shareholders   20,807 20,750 100.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Rising Petrol and Diesel Prices, DHFL Saga, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session marginally higher yesterday. On the sectoral front, gains were seen in the metal sector and realty sector.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - CIPLA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS